Raphaela Sapire

building @baselinerx. now tweeting about peptides. Previously COO @uniswapfnd @livepeer @acumen @bankofamerica.

[Raphaela Sapire @RaffiSapire]

@BobbyThakkar Is this what you produced?

[Raphaela Sapire @RaffiSapire]

@buffalu__ get a grip guys

[Raphaela Sapire @RaffiSapire]

@Nads_Shariff I’m launching a peptide company and have a newsletter writing about my experience building under the hood. What kind of info are you interested in?

[Raphaela Sapire @RaffiSapire]

@gregisenberg Come on in babe the water is warm

[Raphaela Sapire @RaffiSapire]

@longevitydotcom I really liked this podcast. The peptide that comes up in conversations most is GHK Cu

[Raphaela Sapire @RaffiSapire]

@maxmarchione Incredible. And Reta on the way.

[Raphaela Sapire @RaffiSapire]

Anyways if you're curious about what you're getting and where, that's a bit of the backstory!

[Raphaela Sapire @RaffiSapire]

Whenever I tell people I'm starting a peptide company, I usually hear of some buddy making boat loads of $$ doing RUO. That is not what I'm doing. My expectation is that as some of the RUO peptides are recategorized as Category 1 these RUO businesses will disappear.

[Raphaela Sapire @RaffiSapire]

FDA looks at the entire context: what you're selling, who you're selling it to, how you're marketing it, what you're saying about it, and how the business actually operates.

[Raphaela Sapire @RaffiSapire]

@buffalu__ Sounds like you booked a shithole

[Raphaela Sapire @RaffiSapire]

Yesterday I had an (alarming) dinner with my pal Nicolae, who’s built a career in AI, previously as cofounder of clay and now focused on AI safety. I haven’t paid attn to the safety risks of rapidly evolving AI. He outlines key data and information we should all be equipped with

[Nicolae Rusan @NicolaeRusan]

My reflections on OpenAI Chief Scientist Jakub Pachocki’s “An Alien Mind” on AI alignment, the pace of progress, and what this moment asks of us as humans. We’ll need breakthroughs in how we cooperate and adapt, alongside breakthroughs in AI. https://t.co/QKANSxfIvB

[Raphaela Sapire @RaffiSapire]

Data ownership. It was important to me to establish full ownership and export rights of all non-clinical customer data.

[Raphaela Sapire @RaffiSapire]

I spoke with four telehealth platforms before selecting mine. Here's the TLDR on what I learned and what matters.

🧵I'll get into three aspects that matter most to me.

[Raphaela Sapire @RaffiSapire]

Payment flow + structure. I wanted to paying a flat fee per patient/prescription. Many states strictly ban percentage-based fee arrangements between marketing entities and clinical practices.